Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping

Bionano Laboratories, the wholly-owned diagnostics subsidiary of Bionano Genomics (Nasdaq: BNGO), received New York State Department of Health approval for optical genome mapping (OGM)-based lab developed tests at University of Rochester Medicine. The approvals cover clinical testing of patients suspected of genetic disorders including reproductive disorders and hematologic malignancies, and for the first time let New York patients access OGM-based cytogenomic testing.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.